Clinical Trials
2 trialsNCT03063632 2023-10-25
Testing the Combination of Two Experimental Drugs MK-3475 (Pembrolizumab) and Interferon-gamma for the Treatment of Mycosis Fungoides and Sézary Syndrome and Advanced Synovial Sarcoma
National Cancer Institute (NCI)
Phase 2 Completed
NCT01957709 2019-07-10
Recombinant Interferon Gamma in Treating Patients With Soft Tissue Sarcoma
Fred Hutchinson Cancer Center
Phase EARLY_PHASE1 Terminated